• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗最佳投资的未来:卫生技术评估方法。

The future of best investing in vaccines: the Health Technology Assessment approach.

作者信息

La Torre Giuseppe, de Waure Chiara, Chiaradia Giacomina, Mannocci Alice, Specchia Maria Lucia, Nicolotti Nicola, Ricciardi Walter

机构信息

Institute of Hygiene, Catholic University of the Sacred Heart, Rome, Italy.

出版信息

Vaccine. 2008 Mar 20;26(13):1609-10. doi: 10.1016/j.vaccine.2008.01.009. Epub 2008 Feb 1.

DOI:10.1016/j.vaccine.2008.01.009
PMID:18289744
Abstract

Over the past two decades, scientific research has led to the development of a huge number of new health technologies, among which new vaccines. The decision process underlying the introduction of a new vaccine will be of particular concern in the future and a useful tool is needed to orientate decision makers towards better allocation of economic resources. Health Technology Assessment (HTA) is a multidisciplinary tool that aims to examine the clinical, economic, organizational, ethical, juridical, social and cultural implications of the introduction or the implementation of a specific technology; it could so represent an innovative and effective approach in order to support decision-making processes.

摘要

在过去二十年中,科学研究催生了大量新的卫生技术,其中包括新疫苗。未来,新型疫苗引入背后的决策过程将备受关注,因此需要一种有用的工具来引导决策者更合理地分配经济资源。卫生技术评估(HTA)是一种多学科工具,旨在审视特定技术引入或实施所带来的临床、经济、组织、伦理、法律、社会和文化影响;因此,它可以成为支持决策过程的一种创新且有效的方法。

相似文献

1
The future of best investing in vaccines: the Health Technology Assessment approach.疫苗最佳投资的未来:卫生技术评估方法。
Vaccine. 2008 Mar 20;26(13):1609-10. doi: 10.1016/j.vaccine.2008.01.009. Epub 2008 Feb 1.
2
Medical technology management: bridging the gap between theory and practice.医学技术管理:弥合理论与实践之间的差距。
Isr Med Assoc J. 2005 Apr;7(4):211-5.
3
Guidance for future HTA applications to vaccines: the HPV lesson.未来疫苗卫生技术评估申请指南:人乳头瘤病毒的经验教训
Hum Vaccin. 2011 Sep;7(9):900-4. doi: 10.4161/hv.7.9.16084. Epub 2011 Sep 1.
4
The role of health technology assessment in the comprehensive evaluation of the impact of immunotherapy on real practice.卫生技术评估在免疫疗法对实际应用影响的综合评价中的作用。
Eur Ann Allergy Clin Immunol. 2007;39 Spec No:4-6.
5
American Society of Clinical Oncology guidance statement: the cost of cancer care.美国临床肿瘤学会指导声明:癌症护理的成本
J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6.
6
Spanish recommendations on economic evaluation of health technologies.西班牙卫生技术经济评价建议。
Eur J Health Econ. 2010 Oct;11(5):513-20. doi: 10.1007/s10198-010-0244-4. Epub 2010 Apr 20.
7
Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.利用健康技术评估支持加拿大循证决策:学术视角。
Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):513-21. doi: 10.1586/erp.11.60.
8
A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.新兴医疗技术研究与应用中的范式转变:基于证据生成的覆盖范围
J Am Coll Radiol. 2008 Nov;5(11):1125-9. doi: 10.1016/j.jacr.2008.06.008.
9
Health technology assessment (HTA): definition, role and use in the changing healthcare environment.卫生技术评估(HTA):在不断变化的医疗环境中的定义、作用及应用。
Eur Ann Allergy Clin Immunol. 2007;39 Spec No:7-11.
10
Historical development of health technology assessment in Thailand.泰国卫生技术评估的历史发展
Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:241-52. doi: 10.1017/S0266462309090709. Epub 2009 Jun 16.

引用本文的文献

1
[Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra].[针对意大利儿童使用四价流感裂解疫苗(Fluenz Tetra)接种流感疫苗的卫生技术评估]
J Prev Med Hyg. 2021 Sep 10;62(2 Suppl 1):E1-E118. doi: 10.15167/2421-4248/jpmh2021.62.2s1. eCollection 2021 Jun.
2
[ (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy].[意大利引入四价结合疫苗进行抗脑膜炎球菌疫苗接种的(卫生技术评估)]
J Prev Med Hyg. 2021 May 13;62(1 Suppl 1):E1-E128. doi: 10.15167/2421-4248/jpmh2021.62.1s1. eCollection 2021 Mar.
3
[Health Technology Assessment of meningococcal B vaccine (Trumenba) in adolescent in Italy].
[意大利青少年群体中B型脑膜炎球菌疫苗(Trumenba)的卫生技术评估]
J Prev Med Hyg. 2019 Dec 19;60(3 Suppl 2):E1-E94. doi: 10.15167/2421-4248/jpmh2019.60.3s2. eCollection 2019 Dec.
4
Virological Surveillance of Influenza in the eight epidemic seasons after the 2009 pandemic in Emilia-Romagna (Northern Italy).意大利北部艾米利亚-罗马涅地区2009年大流行后八个流行季节的流感病毒学监测。
Acta Biomed. 2019 Sep 13;90(9-S):35-44. doi: 10.23750/abm.v90i9-S.8722.
5
[The universal influenza vaccination in children with Vaxigrip Tetra in Italy: an evaluation of Health Technology Assessment].[意大利使用Vaxigrip Tetra对儿童进行通用流感疫苗接种:卫生技术评估]
J Prev Med Hyg. 2018 May 30;59(1 Suppl 1):E1-E86. eCollection 2018 May.
6
Economic evaluation of HBV vaccination: A systematic review of recent publications (2000-2013).乙肝疫苗接种的经济学评估:对近期出版物(2000 - 2013年)的系统评价
Hum Vaccin Immunother. 2016 Sep;12(9):2299-311. doi: 10.1080/21645515.2016.1166328. Epub 2016 Apr 22.
7
How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project.如何将应用于疫苗接种的卫生技术评估(HTA)评价结果传达给决策者和利益相关者?国际药物经济学与结果研究协会(ISPOR)罗马分会项目。
J Prev Med Hyg. 2015;56(4):E150-4.
8
The future of immunization policies in Italy and in the European Union: The Declaration of Erice.意大利及欧盟免疫政策的未来:埃里切宣言
Hum Vaccin Immunother. 2015;11(5):1268-71. doi: 10.1080/21645515.2015.1019980.